Valuation: Jianmin Pharmaceutical Group Co.,Ltd.

Market Cap 4.14B 618M 542M 510M 466M 871M 59.16B 877M 6.12B 2.37B 30.16B 2.32B 2.27B 97.79B P/E 2024
17.5x
P/E 2025 14.2x
Enterprise Value 3.07B 457M 401M 377M 345M 644M 43.77B 649M 4.53B 1.76B 22.32B 1.72B 1.68B 72.35B EV / Sales 2024
1.56x
EV / Sales 2025 1.21x
Free-Float
65.51%
Yield 2024
2.16%
Yield 2025 2.68%
1 day-0.70%
1 week+2.58%
Current month-1.85%
1 month-1.89%
3 months-6.57%
6 months-17.80%
Current year-19.51%
1 week 26.23
Extreme 26.23
27.77
1 month 26.05
Extreme 26.05
29.33
Current year 24.68
Extreme 24.68
35.87
1 year 24.68
Extreme 24.68
41
3 years 24.68
Extreme 24.68
72.3
5 years 24.68
Extreme 24.68
86.78
10 years 13.69
Extreme 13.69
86.78
Manager TitleAgeSince
President 50 2020-09-08
Director of Finance/CFO 54 2018-01-01
Compliance Officer 38 -
Director TitleAgeSince
Chairman 39 2019-09-16
Director/Board Member 55 2011-08-02
Director/Board Member 55 2013-09-05
Date Insider Type Main position Quantity % Market Cap. Importance
12/13/21 Sell

Chairman

5,000 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
-0.70%+2.58%-33.79%-56.79% 623M
-1.64%+1.16%+54.09%+109.07% 1,043B
-0.01%+0.71%+52.44%+67.71% 649B
-0.05%+0.98%+19.08%+73.55% 469B
-0.25%+0.19%+36.95%+45.63% 355B
+0.98%+2.91%+20.59%+27.91% 270B
-1.91%+2.42%+10.41%+12.53% 262B
-1.01%+7.90%+41.59%+51.70% 222B
-0.85%+2.50%+32.32%+101.80% 189B
-2.53%-7.47%-32.63%-60.67% 175B
Average -0.28%+1.58%+20.10%+37.24% 363.36B
Weighted average by Cap. +0.44%+1.34%+35.88%+65.83%

Financials

2024 2025
Net sales 3.5B 522M 458M 431M 394M 736M 50.03B 742M 5.18B 2.01B 25.51B 1.96B 1.92B 82.7B 3.37B 502M 441M 414M 379M 708M 48.1B 713M 4.98B 1.93B 24.52B 1.89B 1.84B 79.51B
Net income 362M 53.97M 47.37M 44.52M 40.71M 76.07M 5.17B 76.63M 535M 207M 2.64B 203M 198M 8.55B 360M 53.62M 47.06M 44.24M 40.44M 75.58M 5.14B 76.14M 531M 206M 2.62B 201M 197M 8.49B
Net Debt -942M -140M -123M -116M -106M -198M -13.44B -199M -1.39B -539M -6.85B -527M -515M -22.22B -1.08B -161M -141M -133M -121M -226M -15.39B -228M -1.59B -617M -7.85B -603M -590M -25.44B
Logo Jianmin Pharmaceutical Group Co.,Ltd.
Jianmin Pharmaceutical Group Co Ltd, formerly Wuhan Jianmin Pharmaceutical Groups Co Ltd, is a China-based company principally engaged in the research and development, manufacturing, wholesale and retail of pharmaceuticals. The Company operates its businesses through two segments. The Pharmaceutical Production and Sales segment is primarily engaged in the production of various types of Chinese patent medicines and sales to pharmaceutical distributors at all levels, including sales to the commercial division within the group that sells to non-hospitals. The Commercial segment is primarily engaged in the purchase of drugs from manufacturers and manufacturers' agents, and then distribution to lower-level distributors, sales to hospitals and retail sales in pharmacies. The Company mainly operates its businesses in the domestic market.
Employees
2,257
Date Price Change Volume
26-09-23 CN¥27.02 -0.70% 832,200
26-09-22 CN¥27.21 -1.34% 1,227,683
26-09-21 CN¥27.58 +4.31% 2,527,776
26-09-18 CN¥26.44 +0.84% 617,941
26-09-17 CN¥26.22 -0.46% 784,300

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600976 Stock